Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion type Assertion NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_head.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion wasGeneratedBy ECO_0000203 NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion wasDerivedFrom lhgdn-20090331 NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion SIO_000772 17962208 NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion evidence source_evidence_literature NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.